Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",heart left ventricle diameter,,RS:0000742,WKY,male,280 days to 266 days,5,,CMO:0000985,heart left ventricle fractional shortening,,,,51.5,%,1.7,3.8013,MMO:0000337,echocardiography,,0.0,,lad occlusion sham,210,days,sham surgical control condition (for 224 days),100303,sham surgical control condition (for 224 days),, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",heart left ventricle diameter,,RS:0000742,WKY,male,280 days to 266 days,16,,CMO:0000985,heart left ventricle fractional shortening,,,,16.8,%,1.6,6.4,MMO:0000337,echocardiography,,0.0,,lad occlusion,210,days,left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days),100304,left anterior descending coronary artery occlusion (for 224 days),furosemide (10 mg/kg/d) (for 161 days), 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",heart left ventricle diameter,,RS:0000742,WKY,male,280 days to 266 days,32,,CMO:0000985,heart left ventricle fractional shortening,,,,18,%,1.5,8.4853,MMO:0000337,echocardiography,,0.0,,lad occlusion,210,days,left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days),100305,left anterior descending coronary artery occlusion (for 224 days),furosemide (10 mg/kg/d) (for 161 days),ramipril (1 mg/kg/d) (for 182 days) 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",heart left ventricle diameter,,RS:0000742,WKY,male,252 days to 238 days,12,,CMO:0000985,heart left ventricle fractional shortening,,,,41.1,%,3.0,10.3923,MMO:0000337,echocardiography,,0.0,,lad occlusion sham,196,days,sham surgical control condition (for 196 days),100348,sham surgical control condition (for 196 days),, 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",heart left ventricle diameter,,RS:0000742,WKY,male,252 days to 238 days,20,,CMO:0000985,heart left ventricle fractional shortening,,,,15.1,%,1.0,4.4721,MMO:0000337,echocardiography,,0.0,,lad occlusion,196,days,left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days),100349,left anterior descending coronary artery occlusion (for 196 days),furosemide (10 ml/kg/d) (for 182 days), 2460,"Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.",heart left ventricle diameter,,RS:0000742,WKY,male,252 days to 238 days,30,,CMO:0000985,heart left ventricle fractional shortening,,,,15.8,%,0.7,3.8341,MMO:0000337,echocardiography,,0.0,,lad occlusion,196,days,left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days),100350,left anterior descending coronary artery occlusion (for 196 days),vehicle control condition (for 182 days),